These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Prevalence of antibodies against hepatitis B antigen (HB Ag) in general population. Khadim MI, Jafarey NA, Zuberi SJ. J Pak Med Assoc; 1979 Jun; 29(6):112-6. PubMed ID: 117142 [No Abstract] [Full Text] [Related]
45. A study of the incidence of Australia antigen and antibody in nonhuman primates. Rivers SL, Keeling M. Vox Sang; 1970 Jun; 19(3):270-2. PubMed ID: 4993778 [No Abstract] [Full Text] [Related]
48. Chronic hepatitis in chimpanzee carriers of hepatitis B virus: morphologic, immunologic, and viral DNA studies. Shouval D, Chakraborty PR, Ruiz-Opazo N, Baum S, Spigland I, Muchmore E, Gerber MA, Thung SN, Popper H, Shafritz DA. Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6147-51. PubMed ID: 6934542 [Abstract] [Full Text] [Related]
52. [Strategies in the therapy of hepatitis B surface antigen (HBsAg-)-positive chronic hepatitis]. Hess G, Meyer zum Büschenfelde KH. Dtsch Med Wochenschr; 1986 Dec 12; 111(50):1933-7. PubMed ID: 2430769 [No Abstract] [Full Text] [Related]
54. [Radioimmunoassay of E antigen and anti-E antibody system of hepatitis B virus]. Novak I, Kselikova M, Urbankova I. Probl Gematol Pereliv Krovi; 1982 Mar 12; 27(3):55-7. PubMed ID: 7088919 [No Abstract] [Full Text] [Related]
55. Infectivity markers in HBsAg chronic carriers and intrafamilial spread of hepatitis B virus infection. Pastore G, Dentico P, Angarano G, Lapedota E, Schiraldi O. Hepatogastroenterology; 1981 Feb 12; 28(1):20-2. PubMed ID: 7216135 [Abstract] [Full Text] [Related]
56. Safety of hepatitis-B vaccines containing intact 20 nm particles. Trepo C, Prince AM, Meliconi R, Eddlestone AL, Williams R, Tage-Jensen U, Nielsen JO. Lancet; 1979 Mar 03; 1(8114):488. PubMed ID: 85067 [No Abstract] [Full Text] [Related]
57. Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc) as a marker of interferon therapy in patients with persistent hepatitis B virus infection. Nakajima E, Tsuji T, Kachi K, Kagawa K, Okanoue T, Takino T, Yamada A, Imanishi J. Biken J; 1987 Mar 03; 30(1):17-23. PubMed ID: 3675547 [Abstract] [Full Text] [Related]
59. Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant. Ogata N, Zanetti AR, Yu M, Miller RH, Purcell RH. J Infect Dis; 1997 Mar 28; 175(3):511-23. PubMed ID: 9041321 [Abstract] [Full Text] [Related]